November 1, 2012
Ameridose, LLC, a drug supply company based in Westborough, Massachusetts, is voluntarily recalling all of its unexpired products in circulation, according to the US Food and Drug Administration (FDA).
This recall is not based on reports of patients with infections associated with any of Ameridose’s products, but the FDA is currently conducting an inspection of Ameridose’s facility and the preliminary findings have raised concerns about a lack of sterility assurance for products produced at and distributed by this facility.
Through its management structure, Ameridose is tied to the New England Compounding Center (NECC), the firm associated with compounded drugs linked to the ongoing fungal meningitis outbreak.
Products from Ameridose can be identified by markings that indicate Ameridose by name or by its company logo. Click here for a complete list of products subject to this recall.
At this time, the FDA is recommending that health care professionals do not need to follow up with patients who received Ameridose products.
Click here for the MedWatch safety alert.